Drug Shortage Report for ACT CELECOXIB
Report ID | 132669 |
Drug Identification Number | 02420155 |
Brand name | ACT CELECOXIB |
Common or Proper name | CELECOXIB 100MG CAP |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CELECOXIB |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | M01AH |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-01-26 |
Estimated end date | Unknown |
Actual end date | 2021-02-05 |
Shortage status | Resolved |
Updated date | 2021-02-12 |
Company comments | Item is Discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-02-12 | French | Compare |
v3 | 2021-02-12 | English | Compare |
v2 | 2021-01-28 | French | Compare |
v1 | 2021-01-28 | English | Compare |
Showing 1 to 4 of 4